Group K Diagnostics is the Technology Category Winner in the 2018 Stellar Startup Awards

PHILADELPHIA, Sept. 17, 2018 /PRNewswire/ -- Group K Diagnostics has been recognized for its disruptive point-of-care solution as the winner of the technology category in the 2018 Stellar Startup Awards.

Created by the Philadelphia Inquirer, the Awards are in the third year of honoring innovative companies. The winners were announced at an awards gala sponsored by MassMutual Greater Philadelphia on Thursday, September 13.

"We appreciate the honor of winning, and the chance to let the public know about our product's technology and the purpose of our products," said Brianna Wronko, founder and CEO of Group K Diagnostics. "The MultiDiagnostic has the capability to change way diagnostics are seen today, allowing fast results and customized treatment plans," Wronko continued.

The MultiDiagnostic is easy-to-use, consisting of a test strip and a suite of software. Clinicians will determine test results in 20 minutes or less and avoid the costs, time, and risks associated with sending samples to an off-site laboratory. Obtaining quantitative, evidence-based results at the point of care enables clinicians to develop more informed care plans, improving overall quality of care.

In addition to Group K's image processing algorithm, the software suite includes a number of valuable features, such as epidemic tracking, inter-hospital record keeping, and a patient portal.

About Group K Diagnostics
Group K Diagnostics is revolutionizing patient care with accurate, fast and affordable diagnoses. Group K's microfluidic point-of-care device, called the MultiDiagnostic, provides test results in 20 minutes, allowing patients to have direct access to their medical results and enabling doctors to adjust medical treatments in a timely manner. The device has the potential to drastically improve quality of patient care. CEO Brianna Wronko founded the Philadelphia-based company in 2016.

Since its invention, Group K's innovation has generated praise in the healthcare and technology industries. Group K was named 2017 Best of the Best by MABA and Most Innovative Company of the 2017 Heart Science Forum. Wronko has also received recognition as the 2018 Spring PACT TiE Top Pitch Event Winner, the semi-finalist in the inaugural Wharton Startup Challenge, winner of the technology category of the 2018 Stellar Startup awards, and the recipient of various other grants and awards.  Group K participated in UPenn's VIP-X and Dreamit.

For more details on Group K Diagnostics, visit groupkdiagnostics.com, email [email protected] or call Brianna Wronko at 201-450-8785.

SOURCE Group K Diagnostics